Intersect ENT, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 15 rows in 2020. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-12-02: Reporting owner BRODERICK PATRICK A; Form 4; Security Stock Options (Right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-12-02: Reporting owner Fernandez Reyna M; Form 4; Security Stock Options (Right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-06-04: Reporting owner Mead Dana G Jr.; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-06-04: Reporting owner MOLL FREDERIC H; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-12-02 | BRODERICK PATRICK A Officer (EVP, GC & Corporate Secretary) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,989 44,989 owned after | $19.89 exercise price | 2020-12-04 | |
| 2020-12-02 | Fernandez Reyna M Officer (Chief Human Resource Officer) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +29,993 29,993 owned after | $19.89 exercise price | 2020-12-04 | |
| 2020-06-04 | Mead Dana G Jr. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,666 9,666 owned after | $11.84 exercise price | 2020-06-08 | |
| 2020-06-04 | MOLL FREDERIC H Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,666 9,666 owned after | $11.84 exercise price | 2020-06-08 | |
| 2020-06-04 | Kline Teresa L. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,666 9,666 owned after | $11.84 exercise price | 2020-06-08 | |
| 2020-06-04 | VERNON W ANTHONY Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,666 9,666 owned after | $11.84 exercise price | 2020-06-08 | |
| 2020-06-04 | Lucchese Cynthia L Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,666 9,666 owned after | $11.84 exercise price | 2020-06-08 | |
| 2020-06-04 | GALLAHUE KIERAN Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,666 9,666 owned after | $11.84 exercise price | 2020-06-08 | |
| 2020-02-03 | CARSCADDEN GWEN R. Officer (Chief People Officer) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,250 13,250 owned after | $26.18 exercise price | 2020-02-05 | |
| 2020-02-03 | Kowalski Christine R Officer (Chief Operating Officer) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,250 19,250 owned after | $26.18 exercise price | 2020-02-05 | |
| 2020-02-03 | Binney Robert H Jr Officer (Chief Commercial Officer) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,870 21,870 owned after | $26.18 exercise price | 2020-02-05 | |
| 2020-02-03 | Lehman David Aaron Officer (EVP & General Counsel) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,270 21,270 owned after | $26.18 exercise price | 2020-02-05 | |
| 2020-02-03 | West Thomas A. Director, Officer (President and CEO) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +78,700 78,700 owned after | $26.18 exercise price | 2020-02-05 | |
| 2020-01-17 | Kline Teresa L. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,355 3,355 owned after | $24.45 exercise price | 2020-01-22 | |
| 2020-01-17 | MOLL FREDERIC H Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,355 3,355 owned after | $24.45 exercise price | 2020-01-22 |